MMA IRA Payer Insights Survey
How the Inflation Reduction Act is Transforming Payer Strategy:
Download the 2024 IRA Payer Insights Report
IRA Payer Insights Survey 4.0 is a comprehensive look into how top payers are adapting to the Inflation Reduction Act’s new healthcare policies. Discover insights from key industry decision-makers covering over 300 million lives, including actionable data on drug pricing, formulary management, and utilization controls.
This report reveals:
- Payer strategies for IRA-driven drug price negotiations and formulary adjustments
- Increased reliance on biosimilars and generics for cost savings and patient access
- Impact of the M3P Program on pharmacy operations, patient adherence, and healthcare delivery
- Evolving management tactics for high-cost drugs, including protected and non-protected classes
Whether you’re in pharmaceuticals, healthcare management, or policy, the insights in this report will equip you to navigate the shifting landscape.
Download now to gain essential, data-driven perspectives and optimize your strategy in response to the IRA.
